Literature DB >> 1732124

Precore mutant hepatitis B virus infection and liver disease.

N V Naoumov1, R Schneider, T Grötzinger, M C Jung, S Miska, G R Pape, H Will.   

Abstract

The type of hepatitis B virus ("wild-type" or precore mutant) in anti-e antigen antibody-positive carriers, viral DNA levels in the serum, and core and e antigen expression in the liver were investigated to search for a possible correlation of these factors with the severity of liver damage. Two major groups of patients were found: the patients in group A were predominantly infected with precore mutant virus and had chronic active hepatitis, expressed nuclear/cytoplasmic core and e antigens in liver biopsy specimens, and usually had high levels of viral DNA in their serum; patients in group B were infected with a mixture of wild-type and mutant viruses, had predominantly chronic persistent hepatitis, showed weaker expression of nuclear core antigen with no cytoplasmic core or e antigen, and had low viremia. A few patients were infected with viruses without precore stop-codon mutation. These data indicate a high prevalence of precore mutant viruses in anti-e carriers with chronic liver disease and suggest that monitoring of virus sequence type and DNA level may be of prognostic value for liver disease sequelae.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732124     DOI: 10.1016/0016-5085(92)90101-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

Review 1.  Pathogenesis of hepatitis B virus infection.

Authors:  Thomas F Baumert; Robert Thimme; Fritz von Weizsäcker
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 2.  What is expected from the pathologist in the diagnosis of viral hepatitis?

Authors:  Helmut Denk
Journal:  Virchows Arch       Date:  2011-02-26       Impact factor: 4.064

3.  High risk of hepatitis B virus reactivation in nucleos(t)ide analogue-induced hepatitis B e antigen seroconverters older than 40 years.

Authors:  Li-Fu Kuo; Chuan-Mo Lee; Chao-Hung Hung; Jing-Houng Wang; Tsung-Hui Hu; Sheng-Nan Lu; Chi-Sin Changchien; Chien-Hung Chen
Journal:  Dig Dis Sci       Date:  2014-05-21       Impact factor: 3.199

4.  In vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replication.

Authors:  Richard A Heipertz; Thomas G Miller; Colleen M Kelley; William E Delaney; Stephen A Locarnini; Harriet C Isom
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

Review 5.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

6.  Mechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta.

Authors:  Hong Tang; Alan McLachlan
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.

Authors:  K Hasegawa; J Huang; S A Rogers; H E Blum; T J Liang
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal.

Authors:  A S Lok; U Akarca; S Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Nucleotide sequence analysis of the precore region in patients with spontaneous reactivation of chronic hepatitis B.

Authors:  T Laskus; J Rakela; M J Tong; D H Persing
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.